Effectiveness of invasive interventions for chronic subdural hematoma: a systematic review

Victor B Amaral1, Rivaldo F Filho1, João V Fernandes1

  • 1Department of Morphology, Federal University of Paraíba, João Pessoa, Paraíba, Brazil.

PubMed

Insights

Managing chronic subdural hematoma (CSDH) with invasive treatments lacks clear guidelines. This review of randomized trials found limited evidence, highlighting the need for individualized patient care and further research on CSDH interventions.

Area of Science:

  • Neurosurgery
  • Neurology
  • Evidence-Based Medicine

Background:

  • Chronic subdural hematoma (CSDH) is a common neurological condition, particularly in the elderly, often presenting with headaches.
  • The optimal invasive treatment strategy for CSDH remains a subject of ongoing debate.
  • This systematic review focuses on assessing the efficacy and safety of various invasive interventions for CSDH.

Purpose of the Study:

  • To systematically review randomized clinical trials (RCTs) on invasive interventions for chronic subdural hematoma (CSDH).
  • To evaluate the efficacy and safety of different surgical approaches for CSDH treatment.
  • To synthesize current evidence to inform clinical decision-making for CSDH management.

Main Methods:

  • A comprehensive literature search was conducted across major databases following PRISMA guidelines.
  • Study selection, data extraction, and bias assessment were performed independently by experts.
  • The GRADE approach and RoB 2 tool were utilized to evaluate evidence quality and risk of bias.

Main Results:

  • Four RCTs involving 579 patients were included, examining burr hole craniostomy, twist drill craniostomy, and subdural drainage.
  • One study indicated shorter hospital stays with twist drill craniostomy compared to burr hole craniostomy.
  • Findings on drainage duration and irrigation techniques showed varied outcomes across different studies.

Conclusions:

  • The current evidence base for invasive interventions in CSDH is limited.
  • Individualized treatment decisions considering patient factors, risks, and benefits are crucial.
  • Larger-scale RCTs are necessary to establish definitive guidelines for CSDH treatment.
Abstract